ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,388Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 231

$723K Total Retail Price of All Prescriptions

Rank: 11 out of 231

470 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

33% of this provider’s 470 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 470 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 8,727 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
FUROSEMIDE 436 370 1 6
LISINOPRIL 359 291 2 1
LEVOTHYROXINE SODIUM 311 237 3 3
OMEPRAZOLE 303 244 4 5
AMLODIPINE BESYLATE 240 227 5 4
PRAVASTATIN SODIUM 230 174 6 10
FENTANYL 228 207 S2 7 69
HYDROCODONE-ACETAMINOPHEN 222 159 S3 8 21
ZOLPIDEM TARTRATE 207 133 9 14
RISPERIDONE 206 155 10 34
WARFARIN SODIUM 192 138 11 17
SIMVASTATIN 189 141 12 2
MIRTAZAPINE 169 165 13 25
MORPHINE SULFATE ER 148 114 S2 14 79
GABAPENTIN 147 102 15 15
METFORMIN HCL 146 95 16 7
TRAZODONE HCL 146 122 16 35
SERTRALINE HCL 138 91 18 18
METOPROLOL TARTRATE 136 90 19 12
OXYCONTIN 135 107 S2 20 74
LANTUS 131 87 21 42
CYMBALTA 127 81 22 46
DONEPEZIL HCL 122 122 23 26
OXYCODONE-ACETAMINOPHEN 117 80 S2 24 52
POLYETHYLENE GLYCOL 3350 111 79 25 36
TRAMADOL HCL 107 81 26 16
CITALOPRAM HBR 106 89 27 20
CIPROFLOXACIN HCL 104 90 28 58
ATENOLOL 103 92 29 11
NAMENDA 102 102 30 47
PAROXETINE HCL 100 77 31 70
CARVEDILOL 100 85 31 24
ISOSORBIDE MONONITRATE ER 96 82 33 56
ESCITALOPRAM OXALATE 96 56 33 55
CLOPIDOGREL 93 54 35 44
SYNTHROID 92 88 36 28
METOPROLOL SUCCINATE 88 87 37 13
ALBUTEROL SULFATE 86 78 38 66
TAMSULOSIN HCL 83 72 39 30
LEVETIRACETAM 82 34 40 57
HYDROCHLOROTHIAZIDE 81 74 41 9
ATORVASTATIN CALCIUM 80 38 42 8
SANTYL 80 36 42 105
DIVALPROEX SODIUM 80 66 42 53
NOVOLOG 78 59 45 72
CLONIDINE HCL 77 68 46 63
ENDOCET 75 69 S2 47 49
OXYCODONE HCL 75 61 S2 47 23
QUETIAPINE FUMARATE 73 69 49 39
POTASSIUM CHLORIDE 73 69 49 33
SPIRIVA 70 69 51 61
DIOVAN 70 63 51 27
HYDRALAZINE HCL 67 53 53 82
GLIPIZIDE 66 60 54 71
ADVAIR DISKUS 65 59 55 50
PLAVIX 65 47 55 60
REBIF 61 0 57 207
MUPIROCIN 61 60 57 127
ABILIFY 60 51 59 110
RANITIDINE HCL 58 58 60 51
NYSTATIN 58 53 60 87
KLOR-CON M20 57 29 62 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 8, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.